Morphea-like Skin Lesions Reported in the Phase 3 Long-Term Odanacatib Fracture Trial and Extension in Postmenopausal Women with Osteoporosis

被引：0
|
作者：
Saag, Kenneth G. [1 ]
de Villiers, Tobie [2 ,3 ]
Alexandersen, Peter [4 ]
Jacobe, Heidi [5 ]
Kovarik, Carrie [6 ]
Werth, Victoria P. [7 ]
Leung, Albert [8 ]
Desai-Merchant, Avani [8 ]
Mattaliano, Julie [8 ]
Gurner, Deborah [8 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, Div Rheumatol & Immunol, Birmingham, AL 35294 USA
[2] Univ Stellenbosch, Mediclin Panorama, Cape Town, South Africa
[3] Univ Stellenbosch, Dept Obstet & Gynecol, Cape Town, South Africa
[4] Ctr Clin & Basic Res, Vejle, Denmark
[5] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA
[6] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[7] Philadelphia VAMC, Philadelphia, PA USA
[8] Merck & Co Inc, Kenilworth, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1026
引用
收藏
页数：2
相关论文
共 50 条
  • [21] LONG-TERM DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST TWO YEARS OF THE FREEDOM TRIAL EXTENSION
    Bone, H.
    Chapurlat, R.
    Brandi, M.
    Brown, J.
    Czerwinski, E.
    Daizadeh, N.
    Grauer, A.
    Krieg, M.
    Man, Z.
    Mellstrom, D.
    Radominski, S.
    Reginster, J.
    Resch, H.
    Roman, J.
    Roux, C.
    Cummings, S.
    Libanati, C.
    Papapoulos, S.
    Thiebaud, D.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S527 - S528
  • [22] Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
    Meunier, P. J.
    Roux, C.
    Ortolani, S.
    Diaz-Curiel, M.
    Compston, J.
    Marquis, P.
    Cormier, C.
    Isaia, G.
    Badurski, J.
    Wark, J. D.
    Collette, J.
    Reginster, J. Y.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (10) : 1663 - 1673
  • [23] Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
    P. J. Meunier
    C. Roux
    S. Ortolani
    M. Diaz-Curiel
    J. Compston
    P. Marquis
    C. Cormier
    G. Isaia
    J. Badurski
    J. D. Wark
    J. Collette
    J. Y. Reginster
    Osteoporosis International, 2009, 20 : 1663 - 1673
  • [24] Low Fracture Incidence Is Maintained in Postmenopausal Women ≥75 Years with Osteoporosis with Long-Term Denosumab Treatment.
    Papapoulos, Socrates
    McClung, Michael R.
    Franchimont, Nathalie
    Adachi, Jonathan D.
    Bone, Henry G.
    Benhamou, Claude-Laurent
    Farrerons, Jordi
    Gallagher, J. C.
    Halse, Johan
    Lippuner, Kurt
    Minisola, Salvatore
    Toerring, Ove
    Daizadeh, Nadia
    Wang, Andrea
    Wagman, Rachel B.
    Boonen, Steven
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S830 - S831
  • [25] Low incidence of fracture maintained with long-term denosumab treatment in women aged ≥75 years with postmenopausal osteoporosis
    Papapoulos, S.
    McClung, M. R.
    Ranchimont, N.
    Adachi, J. D.
    Bone, H. G.
    Benhamou, C. L.
    Farrerons, J.
    Halse, J.
    Lippuner, K.
    Man, Z.
    Minisola, S.
    Torring, O.
    Daizadeh, N.
    Wang, A.
    Wagman, R. B.
    Boonen, S.
    AUSTRALASIAN JOURNAL ON AGEING, 2013, 32 : 23 - 23
  • [26] Quarterly intravenous ibandronate injections provide continuing benefits in women with postmenopausal osteoporosis: DIVA study long-term extension
    Recknor, C.
    Lillestol, M.
    Grant, R.
    Neate, C.
    Recker, R. R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S453 - S453
  • [27] Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial
    Watts, N. B.
    Dore, R. K.
    Baim, S.
    Mitlak, B.
    Hattersley, G.
    Wang, Y.
    Rozental, T. D.
    LeBoff, M. S.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (01) : 55 - 61
  • [28] Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial
    N.B. Watts
    R.K. Dore
    S. Baim
    B. Mitlak
    G. Hattersley
    Y. Wang
    T.D. Rozental
    M.S. LeBoff
    Osteoporosis International, 2021, 32 : 55 - 61
  • [29] Forearm Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis: Results from the ACTIVExtend Phase 3 Trial
    Watts, Nelson B.
    Dore, Robin K.
    Baim, Sanford
    Hattersley, Gary
    Williams, Greg
    Wang, Yamei
    Rozental, Tamara D.
    Leboff, Meryl S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 292 - 292
  • [30] A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture
    Palacios, Santiago
    Silverman, Stuart L.
    de Villiers, Tobie J.
    Levine, Amy B.
    Goemaere, Stefan
    Brown, Jacques P.
    Nardone, Fiorenzo De Cicco
    Williams, Robert
    Hines, Teresa L.
    Mirkin, Sebastian
    Chines, Arkadi A.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (08): : 806 - 813
12345